HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tae-Sung Koo Selected Research

KR33493

11/2016Subacute toxicity evaluation of KR-33493, FAF1 inhibitor for a new anti-parkinson's disease agent, after oral administration in rats and dogs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tae-Sung Koo Research Topics

Disease

4Prostatic Neoplasms (Prostate Cancer)
03/2022 - 07/2013
3Amyloidosis
01/2022 - 11/2016
2Macular Degeneration (Age-Related Maculopathy)
01/2021 - 01/2019
1Colorectal Neoplasms (Colorectal Cancer)
04/2022
1Colonic Neoplasms (Colon Cancer)
04/2022
1Amyloid Neuropathies (Amyloid Neuropathy)
01/2022
1Cardiomyopathies (Cardiomyopathy)
01/2022
1Familial Amyloidosis (Hereditary Amyloidosis)
01/2022
1Heart Failure
09/2021
1COVID-19
08/2021
1Neoplasms (Cancer)
03/2021
1Neuroblastoma
01/2021
1Alzheimer Disease (Alzheimer's Disease)
08/2019
1Cerebral Infarction
01/2019
1Deglutition Disorders (Dysphagia)
01/2019
1Glaucoma
01/2019
1Hemorrhage
01/2019
1Necrosis
01/2019
1Retinal Degeneration
01/2019
1Pulmonary Hypertension
09/2018
1Transthyretin-Related Hereditary Amyloidosis
08/2018
1Sepsis (Septicemia)
09/2017
1Parkinson Disease (Parkinson's Disease)
11/2016

Drug/Important Bio-Agent (IBA)

7Pharmaceutical PreparationsIBA
04/2022 - 08/2014
4Prealbumin (Transthyretin)IBA
01/2022 - 11/2016
3tafamidisIBA
01/2022 - 11/2016
2Blood Proteins (Serum Proteins)IBA
08/2018 - 11/2015
2enzalutamideIBA
11/2015 - 08/2014
1PyrazinesIBA
04/2022
1Therapeutic UsesIBA
04/2022
1snake venom protein C activatorIBA
03/2022
1Proteolysis Targeting ChimeraIBA
03/2022
1Amyloid (Amyloid Fibrils)IBA
01/2022
1Biological ProductsIBA
01/2022
1Amyloidogenic ProteinsIBA
01/2022
1DiureticsIBA
09/2021
1Furosemide (Lasix)FDA LinkGeneric
09/2021
1Antiviral Agents (Antivirals)IBA
08/2021
1NiclosamideFDA Link
08/2021
1RNA Helicases (RNA Helicase)IBA
03/2021
1Phosphotransferases (Kinase)IBA
01/2021
1trkB ReceptorIBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2021
1TropomyosinIBA
01/2021
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2021
1Fluorescent Dyes (Fluorescent Probes)IBA
08/2019
1PowdersIBA
01/2019
1Ophthalmic Solutions (Eye Drops)IBA
01/2019
1Protein Kinases (Protein Kinase)IBA
01/2019
1Retinaldehyde (Retinal)IBA
01/2019
1TabletsIBA
01/2019
1Warfarin (Coumadin)FDA LinkGeneric
01/2019
1Sildenafil Citrate (Viagra)FDA Link
09/2018
1Phosphodiesterase 5 InhibitorsIBA
09/2018
1LipopolysaccharidesIBA
09/2017
1YS 49IBA
09/2017
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
09/2017
1quinolineIBA
11/2016
1KR33493IBA
11/2016
1Androgen Receptors (Androgen Receptor)IBA
07/2013
1Androgen Antagonists (Antiandrogens)IBA
07/2013

Therapy/Procedure

3Oral Administration
08/2018 - 11/2015
1Therapeutics
03/2022
1Punctures
09/2017
1Ligation
09/2017